• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌茂基和1-金刚烷基紫杉醇类似物破坏βIII-微管蛋白和βIVa-微管蛋白之间的平衡并抑制结肠癌的生长和侵袭性。

Ruthenocenyl and 1-Adamantyl Paclitaxel Analogs Disrupt the Balance between βIII- and βIVa-Tubulin and Inhibit the Growth and Invasiveness of Colon Cancer.

作者信息

Ciszewski Wojciech M, Kowalczyk Karolina, Błauż Andrzej, Ciesielski Wojciech, Hogendorf Piotr, Smolarz Beata, Wagner Waldemar, Wieczorek-Błauż Anna, Rychlik Błażej Michał, Romanowicz Hanna, Durczyński Adam, Sobierajska Katarzyna, Plażuk Damian

机构信息

Department of Molecular Cell Mechanisms, Medical University of Lodz, Mazowiecka 6/8, Lodz 92-215, Poland.

Laboratory of Molecular Spectroscopy, Department of Organic Chemistry, Faculty of Chemistry, University of Lodz, Tamka 12, Lodz 91-403, Poland.

出版信息

J Med Chem. 2025 Sep 25;68(18):19062-19075. doi: 10.1021/acs.jmedchem.5c01147. Epub 2025 Sep 4.

DOI:10.1021/acs.jmedchem.5c01147
PMID:40907950
Abstract

Taxanes are widely used anticancer agents that stabilize microtubules and arrest cell division. However, their efficacy in colon cancer is limited by the chemoresistance associated with βIII-tubulin (TUBB3) upregulation. Herein, ferrocenyl, ruthenocenyl, and 1-adamantyl analogs of paclitaxel were synthesized and biologically evaluated. All compounds exhibited significantly higher cytotoxicity than paclitaxel, with IC values in the nanomolar range. Ruthenocenyl and 1-adamantyl analogs effectively inhibited both growth and invasiveness of colon cancer cells. These effects correlated with altered tubulin isoform expression (downregulation of βIII-tubulin and upregulation of βIVa-tubulin) were associated with modulation of the focal adhesion complex. Specifically, changes in microtubule interactions with the integrin-linked kinase-integrin-β1 axis contributed to a reduced invasive potential. The unique properties of these analogs suggest their potential for dual-action therapy combining tumor growth inhibition with metastasis prevention.

摘要

紫杉烷类是广泛使用的抗癌药物,可稳定微管并阻止细胞分裂。然而,它们在结肠癌中的疗效受到与βIII-微管蛋白(TUBB3)上调相关的化疗耐药性的限制。在此,合成了紫杉醇的二茂铁基、钌茂基和1-金刚烷基类似物并进行了生物学评估。所有化合物均表现出比紫杉醇显著更高的细胞毒性,IC值在纳摩尔范围内。钌茂基和1-金刚烷基类似物有效抑制了结肠癌细胞的生长和侵袭性。这些作用与微管蛋白亚型表达的改变(βIII-微管蛋白下调和βIVa-微管蛋白上调)相关,与粘着斑复合物的调节有关。具体而言,微管与整合素连接激酶-整合素-β1轴相互作用的变化导致侵袭潜能降低。这些类似物的独特性质表明它们具有将肿瘤生长抑制与转移预防相结合的双重作用疗法的潜力。

相似文献

1
Ruthenocenyl and 1-Adamantyl Paclitaxel Analogs Disrupt the Balance between βIII- and βIVa-Tubulin and Inhibit the Growth and Invasiveness of Colon Cancer.钌茂基和1-金刚烷基紫杉醇类似物破坏βIII-微管蛋白和βIVa-微管蛋白之间的平衡并抑制结肠癌的生长和侵袭性。
J Med Chem. 2025 Sep 25;68(18):19062-19075. doi: 10.1021/acs.jmedchem.5c01147. Epub 2025 Sep 4.
2
Design and synthesis of novel 4-aryl-2-benzoyl-imidazoles as colchicine binding site inhibitors.新型4-芳基-2-苯甲酰基咪唑作为秋水仙碱结合位点抑制剂的设计与合成
Eur J Med Chem. 2025 Nov 15;298:118021. doi: 10.1016/j.ejmech.2025.118021. Epub 2025 Aug 4.
3
Discovery of pyrazolo[1,5-a]pyrimidines: Synthesis, in silico insights, and anticancer activity via novel CDK2/Tubulin dual inhibition approach.吡唑并[1,5-a]嘧啶的发现:通过新型CDK2/微管蛋白双重抑制方法的合成、计算机模拟洞察及抗癌活性
Bioorg Chem. 2025 Aug 5;164:108792. doi: 10.1016/j.bioorg.2025.108792.
4
Synthesis and apoptotic induction of sulfonamide-based chalcone hybrids as first-in-class dual histone deacetylase‑carbonic anhydrase inhibitors with potential anti-tubulin activity.基于磺胺的查耳酮杂化物的合成及其凋亡诱导作用,作为具有潜在抗微管蛋白活性的一流双组蛋白脱乙酰酶-碳酸酐酶抑制剂。
Bioorg Chem. 2025 Jun 20;163:108694. doi: 10.1016/j.bioorg.2025.108694.
5
Discovery of novel 1,2,3-triazole arylamide derivatives bearing dithiocarbamate moiety as dual inhibitors of tubulin and LSD1 with potent anticancer activity.发现带有二硫代氨基甲酸盐部分的新型1,2,3-三唑芳基酰胺衍生物作为微管蛋白和赖氨酸特异性去甲基化酶1的双重抑制剂具有强大的抗癌活性。
Eur J Med Chem. 2025 Oct 15;296:117879. doi: 10.1016/j.ejmech.2025.117879. Epub 2025 Jun 24.
6
Unveiling Benzoxazole-Substituted Thiazolyl-Pyrazole Derivatives Inducing Apoptosis by Targeting β-Tubulin and Caspase-3.揭示通过靶向β-微管蛋白和半胱天冬酶-3诱导细胞凋亡的苯并恶唑取代噻唑基吡唑衍生物
ChemMedChem. 2025 Sep 11;20(17):e202500320. doi: 10.1002/cmdc.202500320. Epub 2025 Jul 28.
7
Novel 3,4-diaminothieno[2,3-b]thiophene-2,5-dicarbohydrazide-based scaffolds as EGFR, EGFR, and tubulin polymerization inhibitors with anti-proliferative activity.新型基于3,4-二氨基噻吩并[2,3-b]噻吩-2,5-二碳酰肼的支架作为表皮生长因子受体(EGFR)、微管蛋白聚合抑制剂并具有抗增殖活性。
Bioorg Chem. 2025 Aug;163:108728. doi: 10.1016/j.bioorg.2025.108728. Epub 2025 Jul 8.
8
Isoxazole-Based Compounds Targeting the Taxane-Binding Site of Tubulin.靶向微管蛋白紫杉烷结合位点的异恶唑类化合物。
Arch Pharm (Weinheim). 2025 Jul;358(7):e70031. doi: 10.1002/ardp.70031.
9
Design, synthesis, and biological evaluation of pyrazole-based combretastatin A-4 analogues as potential cytotoxic agents.基于吡唑的康普他汀A-4类似物作为潜在细胞毒性剂的设计、合成及生物学评价
Bioorg Chem. 2025 Jun 16;163:108691. doi: 10.1016/j.bioorg.2025.108691.
10
Design, synthesis and biological activity of tubulin inhibitors based on the structure of deoxypodophyllotoxin.基于脱氧鬼臼毒素结构的微管蛋白抑制剂的设计、合成及生物活性
Bioorg Chem. 2025 Aug;163:108783. doi: 10.1016/j.bioorg.2025.108783. Epub 2025 Jul 20.